An update patent review of MDM2-p53 interaction inhibitors (2019-2023)
{{output}}
Introduction: The activity of the major tumor suppressor protein p53 is disrupted in nearly all human cancer types, either by mutations in TP53 gene or by overexpression of its negative regulator, Mouse Double Minute 2 (MDM2). Th... ...
